RISPERDALCONSTA L.P. - RISPERDALCONSTA LP - CT 7257 - English version
-
10
pages
-
English
-
Documents
-
2010
Écrit par
Has
Publié par
haute-autorite-sante-troubles-mentaux-et-comportementaux
-
10
pages
-
English
-
Documents
-
2010
Description
Introduction RISPERDALCONSTA L.P. 25 mg/2 ml, powder and solvent for prolonged-release suspension for injection in prefilled syringe (CIP: 362 491-3) RISPERDALCONSTA L.P. 37.5 mg/2 ml, powder and solvent for prolonged-release suspension for injection in prefilled syringe (CIP: 362 493-6) RISPERDALCONSTA L.P. 50 mg/2 ml, powder and solvent for prolonged-release suspension for injection in prefilled syringe (CIP: 362 494-2) Posted on May 24 2011 Active substance (DCI) risperidone ATC Code N05AX08 Laboratory / Manufacturer JANSSEN-CILAG RISPERDALCONSTA L.P. 25 mg/2 ml, powder and solvent for prolonged-release suspension for injection in prefilled syringe (CIP: 362 491-3) RISPERDALCONSTA L.P. 37.5 mg/2 ml, powder and solvent for prolonged-release suspension for injection in prefilled syringe (CIP: 362 493-6) RISPERDALCONSTA L.P. 50 mg/2 ml, powder and solvent for prolonged-release suspension for injection in prefilled syringe (CIP: 362 494-2) Posted on May 24 2011
-
Publié par
-
Publié le
05 mai 2010
-
Licence :
Paternité, pas d'utilisation commerciale, partage des conditions initiales à l'identique -
Langue
English
Ajouté à mes notifications
Vous serez informé des prochaines publications.